MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a novel ...

The Kerala government on Tuesday requested the Union Finance Ministry to reverse a ₹3,323 crore reduction in its market ...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...

Poster #13190: AI-Assisted Lung Cancer Screening ... To subscribe to Press releases from this issuer, visit the Subscription to Company news section in your account section or create an account.

announced today that the Company will attend two major health conferences and present posters on its Software as a Medical Device (SaMD) eyonis® LCS, for Lung Cancer Screening. The eyonis® LCS ...

Poster #13190: AI-Assisted Lung Cancer Screening: Results from REALITY, a Pivotal Validation Study of an AI/ML-Based Software Poster Session: B110 - The road to Early Detection: Advancing Lung ...

Presenting your poster at a Labroots Virtual Event can provide valuable research insights and feedback from peers in the comfort of your home or office. Every Labroots virtual event features a virtual ...

Erasca will also present potential first-in-class examples of direct SMP complex inhibitors, representing a new approach to block the RAS/MAPK pathway SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- ...

The posters will be available online at ... We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts ...

Besides presentations and publications, scientific posters are a tried and tested medium for presenting results at conferences and meetings. The strength - and at the same time the challenge - of the ...

An oral presentation will highlight the results of the company’s Phase 2 RAINBOW study. Additionally, five poster presentations (one being a collaboration with patient organisations) will showcase ...